In two sequential studies, the homogeneity of FLT3 pathway signaling abnormalities observed in FLT3 ITD AML samples (compared to normal BM and FLT3 WT AML) was verified and shown to be correlated with FLT3 ITD mutational load [27]. The gene discussed is FLT3; the disease is acute myeloid leukemia.